Bridgefront Capital, LLC

Position in PFE — Pfizer Inc

CIK 1725690 AUSTIN, TX

Position in PFE

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,435,071

-$1,419,788 QoQ

Shares Held

59,596

-48.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.38%

of 13F equity value

Holder Rank

#1,113

of 2,821 holders

Holding Since

Dec 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Bridgefront Capital, LLC holds $6,932,010 across 7 Drug Manufacturers - General names. PFE ranks #3 (20.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	7,888	$2,003,315
2	GILD	Gilead Sciences, Inc.	15,448	$1,951,700
3	PFE	Pfizer Inc This page	59,596	$1,435,071
4	LLY	ELI LILLY & Co	467	$560,133
5	NVS	Novartis AG	3,062	$479,876
6	GSK	GSK plc	6,458	$338,528
7	OGN	Organon & Co.	12,067	$163,387

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,435,071	59,596	-48.0%	Shares	Sole	2026-08-14
2025-12-31	$2,854,859	114,653	+368.0%	Shares	Sole	2026-02-13
2025-06-30	$593,783	24,496	-73.5%	Shares	Sole	2025-08-14
2025-03-31	$2,338,147	92,271	+231.1%	Shares	Sole	2025-05-15
2024-12-31	$739,364	27,869	-23.6%	Shares	Sole	2025-02-14
2024-09-30	$1,055,239	36,463	-51.2%	Shares	Sole	2024-11-14
2024-06-30	$2,092,372	74,781	+234.4%	Shares	Sole	2024-08-14
2024-03-31	$620,545	22,362	-1.1%	Shares	Sole	2024-05-15
2023-12-31	$650,913	22,609	-20.3%	Shares	Sole	2024-02-14
2023-09-30	$940,867	28,365	+269.2%	Shares	Sole	2023-11-14
2023-06-30	$281,775	7,682	+30.9%	Shares	Sole	2023-08-14
2023-03-31	$239,414	5,868	-36.0%	Shares	Sole	2023-05-15
2021-09-30	$394,272	9,167	-75.8%	Shares	Sole	2021-11-12
2020-12-31	$1,392,227	37,822	—	Shares	Sole	2021-02-12
No filing history on record for this holder in this stock.